ARMI | BioFabUSA will sponsor and attend the Rockwell Automation Fair 2025, taking place November 17–20 in Chicago, IL. With a focus on the PharmaSuite User Group, ARMI will engage with leaders across automation, digital systems, and the life sciences industry to advance smart biomanufacturing.
As the field of regenerative medicine continues to evolve, the integration of advanced automation and digital controls is critical to achieving scalable, cost-effective biomanufacturing. At Rockwell Automation Fair 2025, ARMI will explore the role of intelligent automation in transforming production workflows and improving consistency, traceability, and data-driven decision-making in life sciences manufacturing.
Through its sponsorship and presence at the event, ARMI will:
This engagement reflects ARMI’s strategic focus on operational excellence, digital innovation, and systems integration in the biomanufacturing space. ARMI looks forward to contributing to the broader conversation around how automation technologies can accelerate the translation of regenerative medicine breakthroughs into commercial success.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
